Home › Studies › PRJNA1417478
PRJNA1417478 SRP673880

Bifidobacterium probiotic & gut microbiota during travel

Data of Feces Analyzed by Metagenomics Bifidobacterium Supplementation Maintains Gut Microbiota Stability and Enhances Well-Being During Short-Term Travel

80 fecal samples from healthy adults in a randomized, double-blind, placebo-controlled trial testing multi-strain Bifidobacterium probiotic supplementation on gut microbiota stability during a short trip from China to Japan. machine-written summary

80 samples · 80 runs · CN · Adult · 2026 · 10.61 Gbp / sample

Sources
✓Sequence archive 560✓Abstract / description 160○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive560 sample values (collection date, country, intervention, latitude, longitude, subject id, timepoint)
✓ Abstract / description160 sample values (health condition, health condition detail)
○ Full textread; no usable statement or table · PMC12935942
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

RProbiotic (live microorganisms; single strain or mixture): 1 people · 44 samplesprobiotic 1 people · 44 samplesControl / pre-intervention baseline (sample level only): 1 people · 36 samplesno intervention 1 people · 36 samples
randomised to parallel arms

Probiotic (live microorganisms; single strain or mixture) design randomized_controlled_trial · population healthy_control · Multi-strain Bifidobacterium probiotic vs placebo during 5-day travel

“randomized, double-blind, placebo-controlled study” — abstract:41769651 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult80
Condition
healthy_control80
Country
CN80
Body site
primary80
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 1 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 30 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 49 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 10.61 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

2 of 2 people sampled more than once (80 samples; median 40, up to 44 per person) · follow-up median 5 d (max 5 d) · median interval between samples 5 d (time from visit codes mapped to the stated schedule). Schedule stated by the source: “stool collected before departure (Day 0) and after return (Day 5)” (time origin: baseline); stated follow-up 5 d.

CONCON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 0CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5CON: day 5PROPRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 0PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 5PRO: day 50 d1 d2 d4 d5 d

Each row is one person (2 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 10.3%Phocaeicola 8.2%Faecalibacterium 7.7%Prevotella 5.8%Escherichia 5.7%Alistipes 5.2%Bifidobacterium 4.6%Blautia_A 3.3%Roseburia 2.9%Gemmiger 2.0%Collinsella 1.9%Mediterraneibacter 1.7%not assigned to a genus 4.1%other genera 36.8%

Genera, mean relative abundance over 79 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category80 100%
country80 100%80
health_condition80 100%80
subject_id80 100%80
collection_date80 100%80
health_condition_detail80 100%80
intervention80 100%80
latitude80 100%80
longitude80 100%80
timepoint_label80 100%80
Papers (1)
  • <i>Bifidobacterium</i> supplementation maintains gut microbiota stability and enhances well-being during short-term travel. 2026 PMID 41769651 PMC12935942 own_data
Details
Archive description

We analyzed data of gastrointestinal microbiota in feces collected from the subjects

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Data of Feces Analyzed by Metagenomics”
  • body site study.description · “analyzed data of gastrointestinal microbiota in feces”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN54995908collection_date2025-05-31/2025-06-05R10.90biosample.attribute:collection_date2025-05-31/2025-06-05
SAMN54995908countryCNR10.90sample.attr.geo_loc_nameChina
SAMN54995908health_conditionhealthy_controlR40.50paper.abstractForty healthy adults were randomly assigned
SAMN54995908health_condition_detailhealthy adults receiving probiotic or placebo interventionR40.50paper.abstractForty healthy adults
SAMN54995908interventionprobioticR10.70sample.name_rule:library_namePRO_BEF_1
SAMN54995908latitude31.0000R10.90biosample.attribute:lat_lon31 N 121 E
SAMN54995908longitude121.0000R10.90biosample.attribute:lat_lon31 N 121 E
SAMN54995908subject_idPROR10.70sample.name_rule:library_namePRO_BEF_1
SAMN54995908timepoint_labelbeforeR10.70sample.name_rule:library_namePRO_BEF_1
Sequencing

80 runs over 80 samples · mean 10.98 Gbp per run (median 10.61 Gbp, total 878.17 Gbp; 80 runs with a base count) · layout PAIRED 80 · platform ILLUMINA 80 · models Illumina NovaSeq 6000 (80) · 99% of runs with a Sandpiper profile · first public 2026-02-10

Authors (12)

Wang L first · Yu Y · Shen X · Li X · Wang D · Zhai Y · Jiang W · Zhao W · Yu Q · Liong MT · Chen D · Zhao A last

Downloads

PRJNA1417478.csv.gz (2.7 KB) · parquet (73.4 KB) — all 80 samples, every field with route and confidence · PRJNA1417478_determinations.csv.gz (5.5 KB) — 720 evidence rows

Samples (80 · every field this project has values for · hover a cell for its source)
Loading the sample table…